Globenewswire
Search documents
Beyond Oil Announces Meeting of Shareholders
Globenewswire· 2026-02-23 13:00
VANCOUVER, British Columbia, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Beyond Oil Ltd. (TSX: BOIL) (OTCQB: BEOLF) (“Beyond Oil” or the “Company”), a food-tech innovation company dedicated to reducing health risks associated with fried food while lowering operational costs, minimizing waste and enhancing sustainability, today announced that it will hold a Special Meeting of Shareholders (the “Special Meeting”) on Thursday, March 12, 2026, at 8:00 a.m. (Pacific time). The Company intends to continue, subject to recei ...
LYB announces updated 2030 sustainability goals
Globenewswire· 2026-02-23 13:00
HOUSTON, Feb. 23, 2026 (GLOBE NEWSWIRE) -- LyondellBasell (NYSE:LYB) today announced updates to its 2030 climate and circularity goals amid the need for disciplined capital allocation, evolving market conditions and regulatory developments. The goals remain ambitious, while balancing the need to adjust for near-term achievability. The company’s three-pillared strategy remains unchanged: growing and upgrading the core, building a profitable circular and low-carbon business, and stepping up performance and cu ...
CG Oncology to Present at the TD Cowen 46th Annual Health Care Conference
Globenewswire· 2026-02-23 13:00
IRVINE, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON) today announced that Arthur Kuan, Chairman & Chief Executive Officer, and Ambaw Bellete, President & Chief Operating Officer, will present at the TD Cowen 46th Annual Health Care Conference on Monday, March 2, 2026, at 3:10 pm ET. The conference is taking place at the Boston Marriott Copley Place in Boston, MA. Interested parties may access the live audio webcast for this conference from the Investor Relations section of the ...
MBX Biosciences to Participate in Upcoming March Investor Conferences
Globenewswire· 2026-02-23 13:00
CARMEL, Ind., Feb. 23, 2026 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced that Kent Hawryluk, President and Chief Executive Officer, and Sam Azoulay, M.D., Chief Medical Officer, will participate in the following upcoming March investor conferences: Citizens Life Sciences Conference Date ...
Geron Plans to Present at Upcoming Investor Conferences
Globenewswire· 2026-02-23 13:00
FOSTER CITY, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that members of the management team are scheduled to present at the following investor conferences: TD Cowen 46th Annual Healthcare ConferenceFireside Chat on Monday, March 2 at 1:10 p.m. ET in Boston, MABarclays 28th Annual Global Healthcare ConferenceFireside Chat on Tuesday, March 10 at 10:30 a. ...
Avenue Therapeutics Enters into Exclusive Worldwide License Agreement for ATX-04 for the Treatment of Pompe Disease
Globenewswire· 2026-02-23 13:00
ATX-04 is a selective β2-adrenergic agonist with human proof-of-concept data demonstrating improved muscle function and enhanced response to enzyme replacement therapy MIAMI, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (OTC: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for rare and neurologic diseases, today announced that it has entered into an exclusive worldwide license agreement with Duke University fo ...
Alignment Healthcare to Present at the Leerink Partners Global Healthcare Conference
Globenewswire· 2026-02-23 13:00
ORANGE, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that it will present at the Leerink Partners Global Healthcare Conference in Miami, Florida, on Tuesday, March 10, at 3:40 p.m. EST. A webcast and replay of the presentation will be available on Alignment’s investor relations website at https://ir.alignmenthealth.com/. About Alignment HealthcareAlignment Health is championing a new path in senior care that empowers members to age well and live their ...
Boston Legacy FC Announces Sensory Room Sponsorship with Collegium Pharmaceutical
Globenewswire· 2026-02-23 13:00
BLFC Sensory Room Image of future sensory Collegium Pharmaceutical Sensory Room for BLFC home matches Scoreboard for BLFC Scoreboard at BLFC Matches at White Stadium with Collegium Branding BOSTON, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Boston Legacy FC today announced a multi-year partnership with Collegium Pharmaceutical, an emerging biopharmaceutical leader in the Boston area, naming the company an Official Partner of Boston Legacy FC. Through this collaboration, Boston Legacy FC and Collegium are w ...
B2Gold Announces Leadership Transition
Globenewswire· 2026-02-23 13:00
VANCOUVER, British Columbia, Feb. 23, 2026 (GLOBE NEWSWIRE) -- B2Gold Corp. (TSX: BTO, NYSE AMERICAN: BTG, NSX: B2G) (“B2Gold” or the “Company”) today announced that as part of the Company’s leadership succession planning, Mr. Clive Johnson has decided to retire from his role as President, Chief Executive Officer (“CEO”) and Director of the Company at the Annual General Meeting of the Company scheduled to be held on June 4, 2026. The Board of Directors has named Mike Cinnamond, Senior Vice President, Financ ...
Mount Logan Capital Inc. Announces $10 Million Share Repurchase Program
Globenewswire· 2026-02-23 13:00
NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Mount Logan Capital Inc. (Nasdaq: MLCI) (“Mount Logan” or the “Company”) today announced that its Board of Directors has authorized a share repurchase program of up to $10 million of the Company’s outstanding common stock through December 31, 2027. The authorization reflects the Company’s continued focus on disciplined capital allocation. It follows the February 2026 completion of its $15 million tender offer, which reduced the Company’s common stock issued and ou ...